CompaniesPathway Genomics

Pathway Genomics

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (6)
View all

Total Trials

6

As Lead Sponsor

4

As Collaborator

2

Total Enrollment

3,131

By Phase

NA: 1

By Status

COMPLETED: 3TERMINATED: 2UNKNOWN: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT02808884
NCT02910869
Hover over trial bars to see details

Recent Trials

NCT02910869Collaborator
PREDICT: Nutrigenetic Profile of Patients With Weight Loss Success
N/AUnknown
200 participants
Started: Sep 30, 2016
NCT02808884Collaborator
Cancer DNA Screening Pilot Study (CANDACE)
NACompleted
1,514 participants
Started: Sep 19, 2016 · Completed: Jun 10, 2019
NCT02715102Lead Sponsor
Circulating Tumor DNA in Patients at High Risk for Lung Cancer
N/ATerminated
39 participants
Started: Jun 30, 2016 · Completed: Aug 31, 2017
NCT02778412Lead Sponsor
ctDNA in Patients With Thyroid Nodules
N/ATerminated
66 participants
Started: May 31, 2016 · Completed: Aug 31, 2017
NCT02665299Lead Sponsor
Plasma ctDNA in Patients Undergoing Diagnostic Colonoscopy
N/ACompleted
206 participants
Started: Jan 31, 2016 · Completed: Aug 31, 2017
View all 6 trials →